Copolymer 1 (Cop 1), a synthetic copolymer of amino acids, effective in suppression of experimental allergic encephalomyelitis (EAE) and myelin basic protein (MBP), was shown to bind extensively and promiscuously to the class II MHC molecules on antigen-presenting cells (APC) without prior processing. In the case of human APC, binding has earlier been demonstrated to DR but not DQ or class I molecules. In the present study, we examined whether binding of Cop 1 and MBP affects MHC class II expression on the cell membrane. Biotinylated derivatives of these antigens were used to monitor their direct binding to MHC molecules on living APC by flow cytometry using phycoerythrin-streptavidin, while the levels of MHC surface expression were monitored by staining with FITC-conjugated anti-class I-and class II-specific antibodies. When Cop 1 or MBP were incubated with the APC, intensity of cell staining with anti-DR, but not with anti-DQ or anti-class I antibodies, was significantly increased, compared to the staining of control APC not reacted with these antigens. In contrast, staining intensity was unaffected when p84-102, a human immunodominant epitope of MBP, or ovalbumin (OVA), a protein which undergoes proteolytic degradation prior to binding, were incubated with the APC. Cycloheximide, a protein synthesis inhibitor, had no effect on the enhanced staining intensity with anti-DR antibody of cells treated with Cop 1 or MBP, whereas it inhibited the enhanced staining of both DR and DQ molecules caused by the respective antibodies, in the absence of these antigens. Brefeldin A, a protein transport inhibitor, lowered the levels of staining intensity with anti-DR and anti-DQ antibodies in both cases, with and without antigen added to the APC. Fluorescence microscopic analysis revealed that cells incubated with Cop 1 or MBP, but not with p84-102 or OVA, exhibit both bright staining of the cell membrane and clusters produced by the aggregation of DR molecules with these antigens. Taken together, these observations indicate that Cop 1 and MBP, due to their polyvalent character, lead to increased fluorescence intensity of their complexes with HLA-DR, possibly due to recruitment and clustering of previously synthesized DR molecules. This can explain the efficient binding of these antigens to the MHC class II molecules.
Introduction
Binding to molecules of the MHC is a prerequisite for recogni-formation of their compact dimeric structure (16) (17) (18) . This stabilizing effect suggests that peptide binding would tion of antigenic peptides by T cells (1) (2) (3) (4) . Functional, morphological and biochemical evidence indicates that class II increase the pool of biochemically stable MHC molecules, which may lead to their non-random distribution on the cell MHC molecules associate with processed peptides during biosynthesis (5) (6) (7) (8) (9) (10) (11) (12) . Crystallographic studies revealed that surface. It is likely that clustering of receptors in the membrane, either pre-existing or induced by specific ligands, is antigenic peptides are bound to the groove formed by two α-helices lying parallel on top of a β-sheet on a MHC molecule important not only in transmembrane signaling but also in antigen presentation and other forms of cell-cell communica- (13) (14) (15) (16) . Peptide binding to class II is also essential for the tion. Membrane proteins may oligomerize with substantial levels are not due to de novo protein synthesis, but rather they originate from previously synthesized proteins and depend on lateral contact between molecules (19, 20) or may exist as preformed clusters with local concentrations but no evidence an operating protein transport activity. of direct interaction (21). For example, by monitoring resonance energy transfer by flow cytometry, the ICAM-1 molecule
Methods was shown to be in the proximity of the multichain IL-2 receptor α subunit and HLA class I and HLA-DR molecules APC (22,23). In fact homodimers of ICAM-1 were found to exist on the cell surface as evidenced by chemical cross-linking (24) .
Epstein-Barr virus (EBV)-transformed B cell lines were pre-Very recently, several studies addressed the question of pared from the mononuclear fraction of peripheral blood whether clustering of MHC class I and II molecules is required cells according to Brenner et al. (47) from MS patients for ligand-induced signaling events (25, 26) . In addition, a [donors A, DR3 (DRB1*0301); M, DRw11 (DRB1*1104); P, hierarchical organization of HLA class I molecules in the DR4 (DRBl*0403, 0405); and R, DR7,w11 (DRB1*0701, 1104)]. plasma membrane of human lymphoblastoid cells has been Antigens proposed, based on photobleaching fluorescence resonance energy transfer measurements (27) .
MBP was isolated from spinal cords of mouse white matter Class II molecules present on the B cell surface are a result as described (48) . The synthetic peptide p84-102 of the of constant expression, internalization and recycling (28, 29) human MBP (DENPVVHFFKNIVTPRTPP) was synthesized by B cells. The question of whether recycled molecules also the Merrifield solid-phase method (49), using a peptide syncontribute to the binding of peptides and hence to antigen thesizer 430A (Applied Biosystems, Foster City, CA) and presentation is controversial (30, 31) . Recycled class II molecpurified by HPLC. Cop 1 is a synthetic random copolymer ules may be involved in antigen presentation when APC are prepared by polymerization of the N-carboxyanhydrides of Lincubated with a large excess of a given peptide. In this alanine, γ-benzyl L-glutamate, ε,N-trifluoroacetyl L-lysine and case, peptide binding to class II molecules may result from L-tyrosine, followed by the removal of the protecting groups an exchange process on the cell surface (32). Binding of the (36). The end product is a mixture of random polypeptides synthetic antigen, denoted copolymer 1 (Cop 1), to class II with amino acid composition of Ala (4.1-5.8 residues), Glu molecules on live cells has earlier been shown (33 (39, 40) . The possible mechanisms proposed for the activity of Cop 1 in EAE and MS (41) involve, Biotinylation of the antigens in the first step, binding to class II MHC molecules, following Biotinylation of Cop 1, MBP, p84-102 and OVA was performed which two pathways were shown to be activated: (i) induction at 0°C with biotin-N-hydroxysuccinimide (Sigma) as described of antigen-specific suppressor cells (37,41) and (ii) competiby Mozes et al. (50) . Excess of unreacted biotin was removed tion with myelin antigens for activation of specific effector T by dialysis. Analysis of the biotinylated derivatives (51) cells (42) . We have shown that Cop 1 can inhibit the response showed that on average 52% of Cop 1 molecules, 46% to MBP of various MBP-specific T cell lines and clones, of MBP, 51% of OVA and 100% of p84-102 carried the irrespective of their MHC restriction, only in the presence of biotin moiety. APC, indicating that the site of competition between MBP and Cop 1 is most probably the MHC class II binding site (43) .
Direct binding of biotinylated antigens to APC This indeed is in line with the promiscuous binding of Cop 1 APC (1ϫ10 6 /100 µl) were incubated with biotinylated Cop 1 and MBP to a variety of MHC class II molecules on living (50 µg, 70 µM), MBP (50 µg, 27 µM), p84-102 (20 µg, 110 µM) APC of both mouse and human origin (33) . Cop 1 inhibited or OVA (100 µg, 15 µM), in PBS containing 0.1% BSA for 5 h the binding of intact MBP and its major 84-102 epitope, and at 37°C, followed by incubation with phycoerythrin (PE)even displaced these when already bound, whereas it could streptavidin at 4°C for 30 min. These antigens concentrations not be displaced by them from the MHC class II binding site were previously found to yield optimal binding of each antigen (33) . Moreover, Cop 1 efficiently inhibited the binding to (33, 52) . After each incubation the cells were washed three MHC molecules and also displaced a number of peptides times with the above solution. Thereafter, cells were analyzed corresponding to other potential autoantigens in MS, e.g. PLP by flow cytometry using a FACScan (Becton Dickinson). In and MOG (45, 46) . each analysis 5000 cells were examined. In view of these findings, it was of interest to examine whether the surface expression of MHC encoded molecules
Binding of antibodies to APC is affected by the binding of Cop 1 to various APC. In this report we present data showing that binding of Cop 1 and For monitoring levels of HLA class II and class I molecules on the cell surfaces, cells were stained for 30 min at 4°C with MBP lead to a marked increase in the fluorescence intensity of their complexes with HLA-DR. In addition, Cop 1 and MBP FITC-conjugated mAb (1 µg in 50 µl PBS) anti-DR (clone B-F1), anti-DQ (clone TU169) (Serotec, Oxford, UK) or anti-HLA being polyvalent, probably caused clustering of HLA-DR molecules. Furthermore, we show that these elevated DR class I (A,B,C) (clone G46-2.6) (PharMingen, San Diego, CA). 6 cells/100 µl) were incubated with or without the indicated biotinylated antigens: Cop 1 (50 µg, 70 µM), MBP (50 µg, 27 µM), p84-102 (20 µg, 110 µM) or OVA (100 µg, 15 µM), in PBS containing 0.1% BSA for 5 h at 37°C. Thereafter, cells were washed and incubated for 30 min on ice with PE-streptavidin. For the detection of HLA class II and class I levels, cells were stained with FITC-conjugated anti-DR, anti-DQ or anti-HLA class I (ABC) mAb (1 µg in 50 µl PBS). After each incubation the cells were washed three times with the above solution. Thereafter, cells were analyzed by flow cytometry using a FACScan (Becton Dickinson). In each analysis 5000 cells were examined. Results represent mean Ϯ SD values of three independent experiments. Background values of percentage and the MFI of cell staining in the absence of biotinylated antigens were Ͻ10 and 22 respectively. a Significantly different from cells with no antigen (P Ͻ 0.0001, Student's t-test).
Cells were then washed and analyzed by flow cytometry, as and anti-class I antibodies as described above. Cells were then placed on slides and covered with coverslips for micro-described above. scopic analysis. Samples were viewed for blue fluorescence Inhibition of protein synthesis (FITC) at 488 nm. In order to examine whether de novo protein synthesis is involved in the observed changes in the expression of DR and DQ molecules, cycloheximide (50 µM) was applied to Results the APC (1ϫ10 6 /100 µl) for 5 h at 37°C. Thereafter, cells were stained with FITC-conjugated anti-DR or anti-DQ mAb, Surface expression of MHC class II and class I molecules followed by flow cytometry analysis as described above.
following antigen binding to the APC In order to find out whether and how binding of different types Inhibition of protein transport of antigens affects MHC expression on the surface of APC, Brefeldin A (BFA; 14 µM; Sigma) was employed for assesswe first assayed binding of biotinylated derivatives of Cop 1, ment of inhibition of DR and DQ protein transport, under the MBP, p84-102 and OVA. Our recent studies have demonsame experimental conditions as above for cycloheximide. strated that Cop 1, a random copolymer with an average of Binding of DR and DQ specific mAb to the APC 65 amino acids in length, and MBP, a 180 amino acids long, protein, bound very efficiently and promiscuously to the HLA-In order to study the effect of antibody binding on the DR molecules without prior processing, in contrast to OVA, expression of DR and DQ molecules, APC were incubated which is a globular protein and requires processing (52) . The with mAb (1 µg in 50 µl PBS) anti-DR (clone YE2/36HLK) or levels of cell surface HLA expression were then measured by anti-DQ (clone SPV-L3; Serotec) for 5 h at 37°C. Thereafter, cell staining with mAb specific to DR, DQ or to ABC (class cells were stained with FITC-conjugated anti-DR and anti-DQ I). As shown in Table 1 , biotinylated antigens bound to living mAb, followed by flow cytometry analysis as described above.
APC, derived from two MS patients with different HLA haplo-Direct immunofluorescence analysis types (DR3 and DR4), after 5 h of incubation at 37°C. The binding, as expressed by both percentage of labeled cells APC were incubated with Cop 1, MBP, p84-102 or OVA, washed, and stained with FITC-conjugated anti-DR, anti-DQ and the mean fluorescence intensity (MFI) was very similar irrespective of the HLA haplotype. As previously demon-molecules or to an inhibition of the endocytosis of these molecules. In order to examine if the first possibility applies, strated, Cop 1 and MBP binding resulted in higher MFI than p84-102 or OVA binding (33, 52) . This higher signal is not due we studied the effect of cycloheximide, a protein synthesis inhibitor, on the expression of MHC molecules following to differences in antigen concentration as this was also observed using equimolar concentrations of antigen (33) . It antigen binding to the APC. First, we calibrated the concentration of cycloheximide and the time period required to obtain is also not due to the degree of biotinylation, which was similar for Cop 1, MBP and OVA and even higher for p84-significant inhibition of HLA DR, DQ and class I expression (results not shown). Cycloheximide at 50 µM was found 102 (see Methods). No differences in the binding pattern were observed when human (DR2, DR7 and DRW11) or sufficient for causing Ͼ50% decrease in the fluorescence intensity when incubated with the APC for 5 h at 37°C. When mouse (H-2 s and H-2 d ) APC of other MHC restrictions were employed (results not shown). When APC treated with either cells were treated with Cop 1 or MBP, cycloheximide had no effect on the intensity of staining with anti-DR and anti-DQ Cop 1 or MBP were stained by anti-HLA antibodies, the intensity of cell staining with anti-DR, but not with anti-DQ or antibody, whereas it inhibited the expression of both DR and DQ molecules in the absence of these antigens (Table 3 ). It anti-class I antibodies, was significantly increased, compared to the APC staining without pretreatment by these antigens is worth noting that although MBP and Cop 1 binding did not induce an increase in DQ expression, it prevented the loss ( Table 2) . This was a relatively slow process, since the effect was first determined after 2 h of APC incubation with Cop 1 of DQ staining seen upon incubation of cells with cycloheximide in the absence of any ligand. This may indicate low-or MBP, and lasted for additional 20 h (results not shown). In contrast, intensity of staining was not affected when p84-102, affinity binding of MBP and Cop 1 to some DQ molecules under these experimental conditions. On the other hand, in a human immunodominant epitope of MBP, or OVA were added to the APC (Table 2 ). To rule out the possibility that the presence of cycloheximide, expression of both DR and DQ molecules on cells treated with p84-102 decreased to a the observed effect was due to antigen biotinylation, we have also employed the unlabeled antigens. However, similar similar degree as that when no antigen was added to the APC ( Table 3 ). The intensity of cell staining with anti-ABC results were obtained in both cases. Representative histograms of fluorescence intensities of the different MHC molec-antibody decreased in the presence of cycloheximide, regardless of the antigen employed. It should be noted that compar-ules on human APC following binding of the unlabeled antigens are shown in Fig. 1 .
ison has to be done for data within the same set of experiments (Tables 2 and 3 respectively), as these reflect separate sets Effect of cycloheximide on MHC expression following antigen of experimental results. These observations suggest that Cop binding to the APC 1 and MBP lead to increased fluorescence intensity of their complexes with HLA-DR possibly due to recruitment and/or The increase in the intensity of cell staining by anti-DR antibody may be a result of a process initiated by clustering delay in endocytosis of DR molecules available in the cells, but not by de novo synthesis and expression of HLA proteins. of the MHC molecules by Cop 1 or MBP leading either to an increased de novo synthesis and surface expression of these Antibodies to several DR epitopes were reported to induce their aggregation and subsequent signal transduction (53) . Table 4 . Effect of cycloheximide on the intensity of staining
We thus examined whether cycloheximide has any effect on with anti-DR and anti-DQ mAb of cells pretreated with these the intensity of staining with anti-DR and anti-DQ antibodies, antibodies.
of cells treated with these antibodies. surface expression. complexes with HLA-DR molecules (Tables 1 and 2 , and Fig. 1 ). (ii) The enhanced DR fluorescence induced by these antigens does not require protein synthesis (Table 3) , in contrast to induction with anti-DR or anti-DQ antibodies the intensity of cell staining with anti-DR or anti-DQ antibodies was decreased in all cases, regardless of the antigen (Table 4 ). (iii) Inhibition of the transport of DR molecules to the cell surface membrane results in reduced DR expression employed and even without antigen ( Table 5 ), suggesting that binding of Cop 1, MBP or p84-102 requires the transport of and reduced antigen binding (Tables 5-7 ). (iv) Cop 1 and MBP binding leads to aggregation of HLA-DR molecules on the DR or DQ proteins to the cell surface. Furthermore, the levels of fluorescence intensity of staining with these the surface of APC (Fig. 2) . These observations can explain the efficient binding of Cop 1 and MBP to the MHC class II biotinylated antigens were lower in the presence of BFA (Table 6) . A similar effect of BFA on the intensity of staining molecules.
Effect of BFA on HLA expression following antigen binding to the APC
Our recent studies have directly demonstrated high and was observed when cells were treated with anti-DR or anti-DQ antibodies, instead of antigens (Table 7) . promiscuous binding of biotinylated Cop 1 and MBP to MHC class II molecules on living APC of both mouse and human Clustering of HLA-DR molecules following Cop 1 and MBP origin of various MHC haplotypes (46) . Moreover, we showed binding to the APC that Cop 1 and MBP do not require processing prior to their binding to class II molecules and subsequent presentation Our findings suggested that the increased signal intensity of DR complexes with Cop 1 or MBP cannot be explained by by the APC (52) . We have suggested that the ability of Cop 1 to interact with a large number of different MHC molecules synthesis of new DR molecules. However, it is also possible that aggregation of DR-Cop 1 or DR-MBP complexes is may be due to the fact that Cop 1, which is a mixture of random sequence polypeptides, contains different epitopes/ achieved by binding of these polyvalent antigens to more than one DR molecule on the same cell, resulting in clustering motifs that are able to bind to distinct MHC sites. A complementary explanation is that Cop 1 contains promiscuous class of these receptors on the cell surface.
In order to distinguish between these possibilities, we II binding motif(s). In the case of MBP, several laboratories have demonstrated responses to multiple epitopes of MBP in with biotinylated antigens and anti-DR antibody. In contrast, short processed proteolytic fragments of OVA, or the synthetic MS (56-59). It is thus possible that Cop 1 and MBP, being polyvalent antigens, are capable of binding several DR molec-peptide p84-102 which is an immunodominant epitope of MBP, can bind only one single HLA-DR molecule, as illustrated ules on the same APC, leading to their clustering and colocalization, which results in the higher intensity of cell staining by the peptide binding model to class II molecules (16) . This binding would not affect the distribution of DR molecules. prolongs the lifetime of MHC on the cell surface and increases Several studies have addressed the question of the distributotal cell surface expression of MHC molecules (10) . Presumtion of certain lymphocyte receptors on the cell surface.
ably, this increased level of MHC on the cell surface arises Recent work on lateral organization of lymphocyte receptors from the prolongation of the life-time of the peptide-MHC at the surface of human lymphoblastoid cells has demoncomplexes, as confirmed by recent findings (62, 63) . In the strated the non-random distribution of the ICAM-1 molecule present study, we observed an increase in the fluorescence (23). Using flow cytometry energy transfer, this molecule was intensity of HLA-DR after 2 h of incubation with Cop 1 or MBP, shown to be in close proximity of multichain IL-2 receptor α but not with p84-102 or OVA, and this effect lasted for subunit and HLA class I and HLA-DR molecules. In addition, Ͼ20 h (data not shown). These observations suggest that a hierarchical organization of HLA class I molecules in the stabilization of the MHC structure following peptide binding plasma membrane of human lymphoblastoid cells has been is insufficient to explain the enhancement of fluorescence proposed, based on photobleaching fluorescence resonance intensity due to anti-DR antibody staining. Another possible energy transfer studies (27) . However, no exogenous antigen mechanism is that based on clustering the HLA-DR molecules was employed in the above experiments. Here, we suggest by polyvalent antigens such as Cop 1 or MBP. Also, it is that polyvalent antigen binding causes the aggregation of consistent with the fact that both MBP (64) and Cop 1 HLA-DR molecules.
(unpublished observations) have only minor elements of sec-Of importance is the observation that following DR or DQ ondary structure in solution, which may assist in their polyvalclustering induced by binding of specific antibody, there is ent binding to multiple DR molecules on the same cell. also an increased binding of labeled anti-MHC class II. In Of interest is the finding that BFA had a similar inhibitory this case, however, it is the result of a de novo synthesis of effect on the intensity of cell staining with anti-HLA antibodies, DR and DQ molecules, which are transported to the cell regardless of the ligand added. The cellular effects of BFA, surface, resulting in higher levels of fluorescence intensity. It were shown to cause a rapid and reversible block of the is known that antibodies do act as stimulatory agents, leading transport of newly synthesized proteins out of the ER (65). to enhanced expression of their receptors on the cell surface More recently, the effect of BFA on the processing and (60). The lack of interference between the unlabeled and presentation of exogenous antigens by class I and class II labeled antibodies may be explained by internalization of the molecules was investigated using the human B lymphoreceptor by the first antibody during the incubation period, blastoid cell line JY (66) . Although it was demonstrated and availability of the new molecules due to their synthesis that BFA prevents presentation of endogenously synthesized and transport to the cell surface, for binding of the second antigen to class I-restricted cytotoxic T lymphocytes, compar-FITC-conjugated antibody. Thus the mechanism by which ison by FACS analysis of BFA-treated and untreated cells anti-HLA antibodies lead to increased intensity of their complexes with the corresponding receptors seems to differ from revealed no significant difference in class I surface expression that caused by the binding of Cop 1 and MBP to DR molecules 6 h after addition of the drug. In the present study, however, which do not require protein synthesis. The binding of these the effect of BFA on class II expression was shown by flow polyvalent antigens enhanced the fluorescence staining of cytometry to lower the intensity of class II staining after 5 h DR molecules not by inducing the synthesis of new molecules of incubation (Table 7) . but rather by recruitment and clustering of previously synthe-
The fluorocytometric analysis shows that the binding of the sized DR molecules. Measurements of the surface DR exprespolyvalent Cop 1 and MBP to HLA-DR molecules on the APC sion with Cop 1 following cycloheximide treatment indicate leads to a marked increase in their surface expression. This that more than half of all surface DR molecules are occupied effect is most probably due to clustering of DR molecules by Cop 1. This can be explained by (i) the ability of Cop 1 to induced by the binding of polyvalent antigens, as indicated displace peptides associated with DR molecules (33, 46) , thus by the fluorescence microscopy pictures. More compelling increasing the number of Cop 1 bound sites, and (ii) Cop 1 evidence for clustering might be obtained by biochemical being a polyvalent antigen which does not require processing studies. It also can not be excluded that this effect might be (52), a single Cop 1 molecule can bind to more than one DR due to the involvement of molecules other than HLA-DR, e.g. molecule.
Fcγ receptor on the cell surface. Future studies using anti-The observation that the intensity of cell staining with antireceptor antibodies will address this question. It should be DQ antibodies was unaffected when cells were incubated mentioned that recent work by Pierce et al. (67) demonstrated with Cop 1 or MBP in the presence of cycloheximide has that cross-linking of the B cell antigen receptor increases the important implications for interpretation of the binding data.
rate of internalization of surface receptor and bound antigen, The failure of the DQ expression to decline may reflect binding but does not alter the trafficking pathway. of Cop 1 and MBP to some DQ molecules, which is, however,
In conclusion, we have shown that binding to APC of significantly less than the binding to DR, as shown previously polyvalent antigens Cop 1 and MBP, which do not require by inhibition studies (33) . This low-affinity binding may not processing, leads to increased signal intensity of their comaffect the intensity of cell staining with anti-DQ antibody plexes with HLA-DR, and to clustering which represents (Tables 1 and 2) . aggregation of DR molecules by these antigens, possibly due It is well established that class II molecules have a long to recruitment of previously synthesized DR proteins. These life time on the cell surface, with an estimated half-life of observations can explain the high and efficient binding of40 h for HLA-DR molecules on human lymphoblastoid cells (61) . It is also known that the addition of peptides to APC these antigens to the MHC class II molecules. support by the Government of Lower Saxony, Germany. 
